The likelihood of experiencing an increase in Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index within 208 weeks was lower for patients in the ...
Patients with moderate to severe active systemic lupus erythematosus (SLE) who began treatment with anifrolumab in the TULIP-1 and TULIP-2 trials experienced a statistically significant reduction in ...
Phase 3 trial data show subcutaneous anifrolumab improves BICLA response rates and reduces oral corticosteroid use in ...
Dr. Geraldino’s areas of clinical and research interest include Systemic Lupus Erythematosus (Lupus), Rheumatoid Arthritis, and musculoskeletal ultrasonography. She has been supervising the Lupus ...
Flow Space on MSN
The silent burden of lupus flares: How to advocate for yourself when symptoms don't add up
Lupus is often marked by flares, which is when symptoms are usually more obvious.
Lower likelihood seen for experiencing increase in Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index (HealthDay News) — For patients with moderately to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback